(Q44723883)

5 December 2017

title

Phase II study of alpha-tocopherol in improving the cognitive function of patients with temporal lobe radionecrosis (English)

1 reference

5 December 2017

0 references

Agnes S Chan

1

1 reference

5 December 2017

Mei-Chun Cheung

series ordinal

2

1 reference

5 December 2017

Stephen C Law

series ordinal

3

1 reference

5 December 2017

John H Chan

series ordinal

4

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

5 December 2017

1 reference

5 December 2017

volume

100

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

398-404

1 reference

Association of vitamin E and C supplement use with cognitive function and dementia in elderly men.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11885

Brain injury, edema, and vascular permeability changes induced by oxygen-derived free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11885

Impact of radionecrosis on cognitive dysfunction in patients after radiotherapy for nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11885

7 January 2021

Hippocampal remodeling and damage by corticosteroids: implications for mood disorders.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11885

7 January 2021

Postischemic cerebral lipid peroxidation in vitro: modification by dietary vitamin E.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11885

7 January 2021

Protective effect of alpha-tocopherol on ischemic neuronal damage in the gerbil hippocampus.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11885

7 January 2021

Pretreatment with alpha tocopherol enhances neurologic recovery after experimental spinal cord compression injury

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11885

7 January 2021

Dietary intake of antioxidants and risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11885

7 January 2021

Vitamin E and cognitive decline in older persons

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11885

7 January 2021

Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11885

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11885

7 January 2021

The P1 component of the middle latency auditory potential may differentiate a brainstem subgroup of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11885

7 January 2021

Evidence-based cognitive rehabilitation: recommendations for clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11885

7 January 2021

Role of vitamin E in preventing the oxidation of low-density lipoprotein.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11885

7 January 2021

Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11885

7 January 2021

Cortisol differentially affects memory in young and elderly men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11885

7 January 2021

Identifiers

DOI

10.1002/CNCR.11885

1 reference

5 December 2017

1 reference